Research presented at the American Urological Association (AUA) annual meeting in San Diego, California, has linked the use of oral contraception (OC) and chronic pelvic pain symptoms (CPPS) and pain during sexual climax.
Research presented at the American Urological Association (AUA) annual meeting in San Diego, California, has linked the use of oral contraception (OC) and chronic pelvic pain symptoms (CPPS) and pain during sexual climax.
The researchers compared CPSS in young women who were current OC users with CPSS in non-users. They used an anonymous, Internet-based survey of women aged 18−39 within 2 large university populations. Women were excluded if they were pregnant or if they had a history of endometriosis or pelvic pain.
Of the 932 women studied, 605 women were non-OCP users and 327 were OC users (169 low-dose and 171 normal dose). The researchers found significant differences in the incidence of individual pelvic pain symptoms between OC users and non-users and further differences with low-dose use. Overall low-dose OC users were more likely to report pelvic pain symptoms and more likely to have CPPS than non-users (27.1% vs 17.5%, P=0.045). Conversely, normal-dose OC users were less likely to have pelvic pain symptoms overall than were non-OC users.
Low-dose OCP users were found to have almost twice the incidence of pain or discomfort during or after sexual climax compared to controls (25.2% vs 12.3%, P=0.002). There was no difference between normal-dose OC users and controls. There was a trend towards low-dose OCP users having more perineal pain (15% vs 8.9%, P=0.054) and more pain during urination (14.3% vs 9.0%, P=0.096) than controls. Forty-four percent of respondents reported onset of pain after beginning OC use. These respondents were more likely to meet CPPS criteria than those who had symptoms prior to OC use (62% versus 30.3%, P<0.001).
The research was presented as a moderated poster on May 7, 2013, by Margarita Aponte, MD, of New York University, and colleagues.
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
Permanent contraception use increased in US young adults following Dobbs
January 6th 2025A recent study reported an increase in US young adults seeking permanent contraception methods following the Supreme Court’s Dobbs v Jackson Women's Health Organization decision in 2022, highlighting the need for accessible contraception.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
IUD placement within 48 hours nonsuperior vs 2 to 4 weeks after abortion
November 19th 2024A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.
Read More